REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Takeda Indonesia (Indonesia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: PT Takeda Indonesia Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Takeda Pharmaceutical Company Limited is a global biopharmaceutical company. The company focuses on oncology, inflammatory bowel diseases, and immunology. Takeda is committed to developing medicines for cancer patients and those with rare diseases, with a focus on patient needs and scientific rigor. The company also has a legacy in developing treatments for lysosomal storage disorders and a portfolio of commercial products, late-stage investigational therapies, and pipeline candidates. Takeda claims to have a strong presence in Belgium and a focus on therapeutic areas such as oncology, gastroenterology, and rare diseases.

Headquarters
Kota Jakarta Selatan Kuningan Timur Setia Budi Dki Jakarta
South Jakarta; Jakarta; Postal Code: 12950

Contact Details: Purchase the PT Takeda Indonesia report to view the information.

Website: http://www.takeda.co.id

Basic Information
Total Employees:
Purchase the PT Takeda Indonesia report to view the information.
Outstanding Shares:
Purchase the PT Takeda Indonesia report to view the information.
Registered Capital:
Purchase the PT Takeda Indonesia report to view the information.
Incorporation Date:
July 01, 1971
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
President Commissioner
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Takeda Indonesia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
1.94%
Total operating revenue
1.94%
Total assets
2.93%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?